News
We Now Need A Rapid Response To Economic Revival
India is enforcing one of the largest and strictest coronavirus lockdowns in the world and it is showing the desired results.
Gilead announces results from phase 3 trial of investigational Remdesivir in patients with severe COVID-19
This study sought to determine whether a shorter, 5-day course of remdesivir would achieve similar efficacy results as the 10-day treatment regimen used in multiple ongoing studies of remdesivir.
Radicle Growth-Syngenta launch The Radicle Protein Challenge to invest $1.25m in protein discovery technologies
The application period is open through May 29. Calls on companies of all stages solving protein challenges from plant-based to regenerative Ag can apply for this funding
